Literature DB >> 23127547

EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.

Kang Jin Jeong1, Kyung Hwa Cho, Nattapon Panupinthu, Hoon Kim, Jaeku Kang, Chang Gyo Park, Gordon B Mills, Hoi Young Lee.   

Abstract

Lysophosphatidic acid (LPA) augments proliferation and metastasis of various cancer cells. We recently identified a critical role of the Rho/ROCK pathway for LPA-induced proteolytic enzyme expression and cancer cell progression. In the present study, we elucidate the underlying mechanisms by which LPA induces Rho activation and subsequent cellular invasion, and the reversal of these effects by resveratrol. We observed that both Gi and G13 contribute to LPA-induced EGFR activation. The activated EGFR in turn initiates a Ras/Rho/ROCK signaling cascade, leading to proteolytic enzyme secretion. Further we provide evidence that resveratrol inhibits EGFR phosphorylation and subsequent activation of a Ras/Rho/ROCK signaling. Therefore, we demonstrate a mechanistic cascade of LPA activating EGFR through Gi and G13 thus inducing a Ras/Rho/ROCK signaling for proteolytic enzyme expression and ovarian cancer cell invasion, as well as interference of the cascade by resveratrol through blocking EGFR phosphorylation.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127547      PMCID: PMC5528397          DOI: 10.1016/j.molonc.2012.10.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  33 in total

1.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.

Authors:  N Prenzel; E Zwick; H Daub; M Leserer; R Abraham; C Wallasch; A Ullrich
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.

Authors:  Nicolas G Azios; Suranganie F Dharmawardhane
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

3.  Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.

Authors:  S Y Park; K J Jeong; N Panupinthu; S Yu; J Lee; J W Han; J M Kim; J-S Lee; J Kang; C G Park; G B Mills; H Y Lee
Journal:  Oncogene       Date:  2010-11-22       Impact factor: 9.867

4.  PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.

Authors:  Karen D Cowden Dahl; Reema Zeineldin; Laurie G Hudson
Journal:  Mol Cancer Res       Date:  2007-05-02       Impact factor: 5.852

5.  Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.

Authors:  Dai Shida; Xianjun Fang; Tomasz Kordula; Kazuaki Takabe; Sandrine Lépine; Sergio E Alvarez; Sheldon Milstien; Sarah Spiegel
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

6.  Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.

Authors:  Akiko Horiuchi; Norihiko Kikuchi; Ryosuke Osada; Cuiju Wang; Akiko Hayashi; Toshio Nikaido; Ikuo Konishi
Journal:  Cancer Sci       Date:  2008-11-24       Impact factor: 6.716

7.  The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.

Authors:  Ken-ichi Tabata; Kiyoshi Baba; Akira Shiraishi; Masahiro Ito; Norihisa Fujita
Journal:  Biochem Biophys Res Commun       Date:  2007-09-24       Impact factor: 3.575

8.  Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.

Authors:  Kang Jin Jeong; Soon Young Park; Ji Hye Seo; Kyung Bok Lee; Wahn Soo Choi; Jeung Whan Han; Jae Ku Kang; Chang Gyo Park; Yong Kee Kim; Hoi Young Lee
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

9.  Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis.

Authors:  M J Gardner; L M Jones; J B Catterall; G A Turner
Journal:  Cancer Lett       Date:  1995-05-08       Impact factor: 8.679

10.  Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.

Authors:  Ganapati H Mahabeleshwar; Riku Das; Gopal C Kundu
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  15 in total

1.  Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.

Authors:  Ming-Zhi Zhang; Xin Wang; Haichun Yang; Agnes B Fogo; Brian J Murphy; Robert Kaltenbach; Peter Cheng; Bradley Zinker; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

Review 2.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

3.  Small lipidated anti-obesity compounds derived from neuromedin U.

Authors:  Ewa D Micewicz; Omar S O Bahattab; Gary B Willars; Alan J Waring; Mohamad Navab; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Eur J Med Chem       Date:  2015-07-14       Impact factor: 6.514

4.  EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.

Authors:  Kang Jin Jeong; Kyung Hwa Cho; Nattapon Panupinthu; Hoon Kim; Jaeku Kang; Chang Gyo Park; Gordon B Mills; Hoi Young Lee
Journal:  Mol Oncol       Date:  2012-10-23       Impact factor: 6.603

5.  Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylation.

Authors:  Danielle Kamato; Hang Ta; Rizwana Afroz; Suowen Xu; Narin Osman; Peter J Little
Journal:  J Cell Commun Signal       Date:  2019-07-09       Impact factor: 5.908

6.  High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer.

Authors:  Ke Wang; Dan Li; Lu Sun
Journal:  Onco Targets Ther       Date:  2016-01-19       Impact factor: 4.147

7.  Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780.

Authors:  Laura H Engelke; Alexandra Hamacher; Peter Proksch; Matthias U Kassack
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

8.  Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness.

Authors:  Bo Young Jeong; Kyung Hwa Cho; Se-Hee Yoon; Chang Gyo Park; Hwan-Woo Park; Hoi Young Lee
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

9.  The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells.

Authors:  Hui Cai; Yan Xu
Journal:  Cell Commun Signal       Date:  2013-04-24       Impact factor: 5.712

10.  Resveratrol, Acetyl-Resveratrol, and Polydatin Exhibit Antigrowth Activity against 3D Cell Aggregates of the SKOV-3 and OVCAR-8 Ovarian Cancer Cell Lines.

Authors:  Simon J Hogg; Kenny Chitcholtan; Wafaa Hassan; Peter H Sykes; Ashley Garrill
Journal:  Obstet Gynecol Int       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.